<DOC>
	<DOCNO>NCT00892970</DOCNO>
	<brief_summary>The objective study compare safety efficacy azithromycin ophthalmic solution , 1 % versus placebo two-week treatment period .</brief_summary>
	<brief_title>The Effects Azithromycin Ophthalmic Solution , 1 % Versus Placebo Subjects With Blepharitis During Two-Week Treatment Period</brief_title>
	<detailed_description />
	<mesh_term>Blepharitis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Have best correct visual acuity eye least +0.7 good If female , nonpregnant nonlactating Have current diagnosis blepharitis one eye Have lid structural abnormality Have suspect ocular fungal viral infection Have practice warm compress therapy within 14 day prior Visit 2 Unable withhold use contact lenses treatment followup period Unable withhold use ocular cosmetic product within 24 hour prior study visit Have penetrate intraocular surgery within 90 day prior Visit 2 Have ocular surface surgery within past year prior Visit 2 Have serious medical condition could confound study assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>